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Analysis of Protein-Ligand Interactions of SARS-CoV-2 Against
Selective Drug Using Deep Neural Networks
Natarajan Yuvaraj, Kannan Srihari , Selvaraj Chandragandhi, Rajan Arshath Raja,
Gaurav Dhiman, and Amandeep Kaur
Abstract: In recent time, data analysis using machine learning accelerates optimized solutions on clinical healthcare
systems. The machine learning methods greatly offer an efficient prediction ability in diagnosis system alternative
with the clinicians. Most of the systems operate on the extracted features from the patients and most of the predicted
cases are accurate. However, in recent time, the prevalence of COVID-19 has emerged the global healthcare industry
to find a new drug that suppresses the pandemic outbreak. In this paper, we design a Deep Neural Network (DNN)
model that accurately finds the protein-ligand interactions with the drug used. The DNN senses the response of
protein-ligand interactions for a specific drug and identifies which drug makes the interaction that combats effectively
the virus. With limited genome sequence of Indian patients submitted to the GISAID database, we find that the DNN
system is effective in identifying the protein-ligand interactions for a specific drug.
Key words: Deep Neural Network (DNN); coronavirus; protein-ligand interactions; deep learning; clinical healthcare
system
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Introduction

The Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has increased the mortality across globe.
The prevention of anti-drugs is essential in reducing the
mortality rate at a quicker rate so as to effectively combat
the virus globally[1] .
On one hand, with the advent of computationally
intensive methods, the protein sequencing is made less
expensive and faster. On the other hand, high-cost
experiments and technical difficulties have led to poor
accuracy in finding the protein-ligand interaction, where
the smaller structural details are found[2] . The primary
protein structure (amino acid sequence) and its binding
residue help in direct determination of tertiary protein
structure. Therefore, the binding residues are found
easily through the protein properties, but it fails to reveal
the complex nature of protein structure and binding
residues from the primary structures[3] .
In the field of bioinformatics, the utilization of deep
learning algorithm in recent years helps in the prediction
of binding residues using complex structural mappings.
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It further varies from predicting the RNA-protein
binding, secondary protein structure, and compound
interaction of proteins and contact mapping[4] . The
conventional computation methods using structural
sequencing for the protein-ligand interaction assist in
predicting the binding residues[5] . The deep learning
architectures fit well to work on 3D-structure templates
for binding and mapping. It extensively reduces the
cost associated with template matching in distributed
environment. The other major problem involves the
higher order of 3D protein structure leading to poor
utilization of 3D-structural data, thereby limiting the
prediction of protein binding residues. With deep
learning as the protein structure prediction model, we
model the present study to find the relative drugs most
suitable for treating the SARS-CoV-2 viral infection.
Hence, in this paper, a Deep Neural Network (DNN)
model is designed to find the protein-ligand interactions
of selective drugs, which include ketoamide, lopinavir,
nelfinavir, remdesivir, and ritonavir[6] . We analyze the
protein-interaction behavior of COVID-19 with all the
five drugs using DNN training and testing module.
The main contributions of this work involve the
following:
(1) We develop a deep learning model that involves
in finding the potential drugs against the formation of
protein-ligand interactions of SARS-CoV-2 virus from
the asymptomatic Indian patients based on the limited
datasets collected.
(2) The study is supported by testing the patients
against various drugs reported in Ref. [6], which
include ketoamide, lopinavir, nelfinavir, remdesivir, and
ritonavir.
(3) The optimal protease inhibitors are studied using
the DNN model to find the negative dock value. Among
all the selective inhibitors, the DNN with its repeated
iteration confirms which of the utilized drugs is allowed
to report the most effective binding value in comparison
with the past binding results from Ref. [6].
The outline of the paper is presented below: Section
2 provides the related work. Section 3 discusses
the proposed DNN protein-ligand interaction system.
Section 4 evaluates the entire work. Section 5 provides
the result and discussion. Section 6 concludes the work
with possible directions of future scope.

2

Related Work

Upon reviewing various literatures on finding the
COVID-19 drugs, we found that most of the existing

methods[3–10] were operated on screening the patients
using the CT and X-ray images of chest regions to detect
the COVID-19 symptoms. In addition, with the image
screening process, the authors in Ref. [11] used the
nucleic acid testing (and polymerase chain reaction[12] )
of SARS-CoV-2 for final identification of COVID19 related symptoms. The authors in Ref. [13] aimed
to develop a deep trained neural network model for
finding the effective protein-ligand interaction from three
different datasets, which include homology modelling
and virtual screening on chimdiv database and tripeptide database. The process involves alignment of
protein sequence, virtual screening against four small
compounds, and tri-peptides.
There exist several deep learning algorithms[14]
on predicting the protein structure using deep
learning algorithms, which include feed-forward neural
networks[15] , deep neural networks[16] , recurrent neural
networks[17] , and convolutional neural network[18] .
These methods show the protein structure annotations
that help in describing the structure of proteins based
on the extraction of protein sequence with local and
global conformations to guide the protein folding[19] .
The introduction of deep learning model produces higher
representations by reducing the input dimensionality and
aids in complex protein structures. With such motivation,
the present study predicts the protein structure of SARSCoV-2 patients using DNN, thereby providing insights
on drug development process.

3

Material and Method

Dataset: The RNA sequences are collected from
GISAID database, where they are translated into protein
sequences for building the 3D model for possible DNN
prediction. The RNA strands are collected from Indian
citizens to study the effect of drugs on the SARS-CoV-2
virus.
Drugs considered: The study reports five different
drugs including ketoamide, lopinavir, nelfinavir,
remdesivir, and ritonavir. The binding energy of each
drug with bond length is given as an input to the
DNN model for drug prediction based on protein-ligand
interaction, as shown in Table 1.
Definition of ligand binding residues: Proteinligand interactions were studied extensively in Refs. [20–
24] including drug interaction, carbohydrate recognition,
and DNA binding. In addition, the drug discovery
process considers the ligand binding regions prediction
as an essential component, and DNN is used for such
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Table 1 Binding energy and bond length of COVID-19
protease inhibitors.
Ligand
Binding energy (kcalmol–1 ) Bond length (Å)
Ketoamide
5.80
2.8
Lopinavir
6.08
2.7
Nelfinavir
7.54
3.0
Remdesivir
5.51
2.7
Ritonavir
5.96
2.7
Note: 1 cal4.18 J; Å D 0.1 nm.

prediction purposes. To reduce the adverse effects of the
drugs utilized for the study, we find the location of the
binding sites based on predicting the distance between
the atoms or residues that facilitates in optimizing the
drug discovery process with selective structural features.
These features highly influence the binding selectivity
for limiting the adverse effect of drugs. There exist
several methods on predicting the ligand binding sites
using machine learning methods[25–28] with amino acids
residues as their residues[29–31] . In the present study,
the understanding on ligand interaction with protein
membrane is limited due to unavailability of literatures
as compared with globular proteins.
In this paper, we carry out the protein-ligand
interaction to study the interaction of drugs on protein
structure, which is analyzed by DNN model over several
iterations. We assume the ligand atoms are intact with
residual atoms. If the distance existing between these
two kinds of atoms is less than the cut-off level (4.5 Å),
then the atoms are said to be in binding state. From the
dataset of several residues, we collect protein sequence
of SARS-CoV-2 and then identify the sequence as a
ligand binding residue.
Description of DNN: The architecture of DNN is
given in Fig. 1. DNN is used frequently in several
applications. The performance of DNN network entirely
depends on the optimal selection and arrangement
of network layer. The network training for DNN is
carried out using the learning task. A requirement-based
Input

Fig. 1

Hidden

Output

Architecture of DNN.

pre-trained network is modified and the new protein
sequence dataset is formed into transfer learning.
The general neural network architecture shown in
Fig. 1 consists of an input layer, a hidden layer, and
an output layer. Each layer is selected and arranged on
the basis of the size of output, when a DNN network
is designed from scratch. Initial convolutions are made
based on the various filter sizes. The convolution layer
extracts the protein sequences from the 3D models. The
feature maps are formed and then sub-sampled using
pooling layer, and then the size of feature map reduces
for propagation over upcoming layers.
The activation function in DNN is a Rectified Linear
Unit (ReLU). To reduce the simplicity of computations,
it operates more like a linear activation function than
other activation functions. The rectified linear unit as an
activation function exploits improvements in training
the multi-layered networks with reduced complexity
in contrast with a nonlinear activation function. The
nonlinearity of the DNN model is added in order to
perform more effectively at training for the network.
The DNN layer is completely connected and it
includes an input layer, multiple hidden layer, and an
output layer. The neural network functions consistently,
as each DNN neuron layer is connected to next layer
of a neuron. The result of classification is calculated
using the connected DNN layer based on cut-off value
(as discussed earlier) calculated with softmax layer for
finding the distance between the residuals. Here, after
classifying scores are obtained, the 3D image is classified
into different classes.
Artificial Neural Networks (ANNs) consist of several
artificial neuron nodes that emulate human brain
neurons. In contrast to the biological neurons, there is
only one kind of link between a neuron and others. The
neurons collect input data, which are simple to be
operated. These operations lead to the transmission of
other neurons. The activation function determines if the
result has been passed. The activation function plays an
important role for both extraction and classification of
features.
A multi-layer neural network (Fig. 2) could be
considered stacked. As name suggests, when DNN
contains over a hidden layer and the system moves to
a layer, it is called the Multi-Layer Perceptron (MLP).
These neural networks can be classified and forecast.
When the DNN is used as classification, the input and
output nodes match input and output classes.
The input layer x D fx1 ; x2 ; : : : ; xp g (with activation
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Feed-forward DNN with 3 hidden layers.

function a.1/ of weight W .1/ ) consists of four elements
that can be used to classify one result from another and
identify a pattern in the input entities. For this purpose,
we design a series of hidden units .a.2/ ; a.3/ ; and a.4/ /
with activation functions and weights .W .2/ ; W .3/ ; and
W .4/ /, respectively. Active unit pattern is utilized by
ReLU and other nonlinear activations.
As shown in Fig. 2, the output layer y D fy1 ; y2 ; : : : ;
yp g is activated in hidden layer a.5/ . Weight and
distortion are adjusted for hidden nodes to activate.
Initially, weights and biases are randomly changed. Then
we train our network for the tens of thousands of inputs.
The test uses retrospective error propagation to change
biases and weights in order to activate hidden neurons at
suitable values.
The set or kernel of functions is the set of weights and
partialities, which is used to identify a specific output.
DNN will be assumed to be the key to the solution
when the pattern for discrimination is complex enough to
prevent traditional statistical and numerical approaches.
Pretrained network. The pre-trained network is
amended to match the output requirements, which is one
of the most common methods of learning. There are a lot
of pre-trained user training networks. These pre-trained
networks tend to face a range of training challenges when
they are trained over millions. A comparison of Alexnet,
ResNet-18, and GoogLeNet is discussed. Each of the
three kinds of pre-trained networks brings together two
kinds of layers: convolutional and pooling layers.

4

Proposed Method

In this section, as shown in Fig. 3, the prediction of protein

Input training
data

DNN
(interaction of
drugs over
protein
sequence based
on genetic
features)

Fig. 3 Feature extraction of protein structure using artificial
neural network.

structure from the repository is carried out to virtually
screen the drugs for finding suitable curable drug. The
complexes of protein-ligand are considered as positive
and cross-docking is considered as negative for the input
training datasets. The DNN is a fully connected network
that has the ability to learn more abstract features from
the input training data.
The DNN is modelled as a distance measure to predict
the actual distance between the residual pairs within
the protein-ligand interaction. It directly estimates the
candidate structure’s accuracy and generation of protein
structure. The DNN operates as a template modelling
that sets main protease of SARS-CoV-2 as its template
to perform the prediction of sequence alignment.
The DNN is responsible for sequentially analyzing
the SARS-CoV-2 proteins obtained from the RNA
sequences, where the sequences are initially translated
from the amino acid sequences. The DNN predicts the
proteins by focusing entirely on the ligand binding region
and S protein regions.
Then the virtual screening against all the selected
drugs was performed based on the homology model.
This model consists of the ligand binding region from
the protease of SARS-CoV-2 as its template. The cutoff distance between the residual pair is set as 1 nm
based on the template setting. The ligand database
with millions of components is used as input feature
by the DNN algorithm to perform virtual screening
of drugs. The scalability of the model is regularised
by considering the mean and standard deviation of the
datasets used during normalization of input training
data. With the features collected from the input training
sets, the validation of DNN model is carried out with
docking simulation. The validation provides the results
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5

Result and Discussion

The protein sequence dataset[32] is used for the design
and evaluation on diagnostic validation of drugs
interaction over SARS-CoV-2 virus. The synthesis of
protein sequence from ProteinNet[32] and its interaction
behaviour with the drug used in the present study are
noted at each iteration while training the DNNs. The
simulations of DNN are conducted on Matlab simulator
on a high-end computing machine.
The validation of the trained DNN is carried out by
comparing the test results with existing methods. The
protein synthesis interaction in the validation is carried
out by the test dataset and the classified output is finally
obtained from DNN.
If the accuracy of the prediction is not obtained well,
then the network is altered until the prediction results
are obtained to be precise. This helps to achieve higher
validation accuracy of drug interaction with the protein
synthesis with training progress. The performance of
deep learning algorithm is presented via confusion
tables.
The performance of the proposed method is tested in
terms of accuracy, precision, recall, and F1-score as in
the following equations:
TP C TN
Accuracy D
(1)
TP C TN C FP C FN
TP
Precision D
(2)
TP C FP
TP
(3)
Recall D
TP C FN
Precision  Recall
F1-score D 2 
(4)
Precision C Recall
where TP represents true positive, TN represents true
negative, FP represents false positive, and FN represents
false negative. The performance of different pre-trained
systems is thoroughly analyzed as an early stage in the
development of a DNN for the classification of protein

synthesis. The performance is comparable by three preworked networks: Alexnet, GoogLeNet and ResNet18. In test datasets, the network is initially loaded,
altered, and trained. The networks tend to achieve a
better performance comparison with other performance
parameters once the training has been completed.
The DNN is set with same options to compare them
with parameters and same dataset for specific network
architectures. The networks are trained up to 40
iterations and then the protein data are shuffled and
validated over multiple iterations.
In this paper, we present the frequency of validation
to be five iterations. The set of options can also
accurately trace the training progress and display
the validation accuracy after all three iterations. The
modified pretrained network is trained for the same
number of epochs. Figure 4 presents the classification
accuracy of the three networks.
After training the DNN, the performance of network
is evaluated under different performance metrics and
confusion matrix determines all the performance of
target classes, i.e., drugs interaction. The performance
of DNN is then compared with other algorithms that
include Deep Belief Network (DBN), ANN, FeedForward Neural Network (FFNN), and Back Propagation
Neural Network (BPNN). The performance of the
proposed DNN AlexNet is chosen for final simulation
of finding the accuracy, precision, recall, and F1-score.
The results are evident as shown in Tables 2–6.
The results show that the proposed DNN is effective
in finding the drug interaction with protein sequence.
Out of all the five drugs, the results show that remdesivir
drug is effective in interacting with the protein sequence
0.75
0.70
0.65

Classification accuracy

of compound list that can bind potentially with the
protein-ligand structure. The compounds are then ranked
and the one with high validation score is considered as
an inhibitor for validation of suitable drug to battle the
SARS-CoV-2.
Depending on the input training datasets, the
validation is carried out by the DNN model. It finds
the accuracy of drug interacting with protein sequences
based on the genetic features and input training data. The
results of validation are thus presented in the following
section.

0.60
0.55

AlexNet
ResNet-18
GoogLeNet

0.50
0.45
0.40
0.35
0.30
0.25

0

200

400

600
800
Number of epochs

1000

1200

Fig. 4 Classification accuracy of training models of DNN
with three pre-trained networks.
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Table 2 Performance of ketoamide drug interaction with
SARS-CoV-2 virus over Indian datasets.
Algorithm
Accuracy
Precision
Recall
F1-score
DNN
0.9208
0.9389
0.6064
0.7356
DBN
0.9210
0.9394
0.6100
0.7369
ANN
0.9211
0.9395
0.6152
0.7421
FFNN
0.9220
0.9398
0.6313
0.7529
BPNN
0.9222
0.9399
0.6363
0.7597
Table 3 Performance of lopinavir drug interaction with
SARS-CoV-2 virus over Indian datasets.
Algorithm
Accuracy
Precision
Recall
F1-score
DNN
0.9460
0.9568
0.6968
0.6256
DBN
0.9442
0.9564
0.6786
0.6103
ANN
0.9436
0.9559
0.6751
0.6057
FFNN
0.9429
0.9558
0.6662
0.6024
BPNN
0.9414
0.9542
0.6589
0.5844
Table 4 Performance of nelfinavir drug interaction with
SARS-CoV-2 virus over Indian datasets.
Algorithm
Accuracy
Precision
Recall
F1-score
DNN
0.9665
0.9762
0.9642
0.8958
DBN
0.9587
0.9761
0.9638
0.8956
ANN
0.9452
0.9760
0.9571
0.8854
FFNN
0.9403
0.9758
0.9553
0.8854
BPNN
0.9382
0.9758
0.9544
0.8643
Table 5 Performance of remdesivir drug interaction with
SARS-CoV-2 virus over Indian datasets.
Algorithm
Accuracy
Precision
Recall
F1-score
DNN
0.9969
0.9984
0.9443
0.9155
DBN
0.9968
0.9982
0.9438
0.9151
ANN
0.9961
0.9973
0.9364
0.9015
FFNN
0.9961
0.9973
0.9351
0.9012
BPNN
0.9954
0.9963
0.9270
0.8806

6

In this paper, we design a DNN model for the
potential identification of drugs against the proteinligand interaction of SARS-CoV-2 virus, specifically
in Indian patients. The results of DNN are accurate and
it is quick in finding the antidote among the selective
drugs using virtual drug screening process. The DNN
assists the drug screening process by generating possible
compound and tripeptide list on asymptotic Indian
patients. The rich antiviral property in the nucleic acid
analogue of adenosine and nucleotide analogues used in
remdesivir is found to be effective in combating the viral
property of SARS-CoV-2 infections. The experiments
on protein-ligand interaction provide possible cure by the
remdesivir drug than other selective drugs. The results
are accurate with repeated iterations with the negative
dock value and binding energy value. Depending on
the molecular interaction with protease inhibitors, it is
found that the remdesivir drug provides the instant relief
against the COVID-19 symptoms and possible cures
against the viral infection. In the future, the study may be
developed with a possible combination of reinforcement
learning and deep learning algorithm to deeply analyze
the peptide structure from protein-ligand interaction.
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